Skip to content
Research Article Open access CC BY 4.0

A case report on Transthyretin Cardiac Amyloidosis

G. Ziani, H. Souilk, R. El Azouzi, A. Ameur, N. Doghmi, M. Cherti

International Journal of Medical and Pharmaceutical Case Reports · pp. 52–58 · Published 27 Apr 2024

10.9734/ijmpcr/2024/v17i2376

Abstract

Introduction : Cardiac amyloidosis is due to the extracellular accumulation of insoluble fibrillar proteins which progressively alter the function of the myocardium. The prognosis depends on the severity of the cardiac involvement. Transthyretin cardiac amyloidosis (TTR) is the most common. It can be wild-type (ATTRwt), hereditary (ATTRv) or senile (wild TTR). The diagnosis of cardiac amyloidosis has greatly improved in the last decade and is based on multimodal imaging, mainly echocardiography and bone scintigraphy. Case Report: We report the case of a male patient hospitalized for heart failure due to transthyretin cardiac amyloidosis. Conclusion:  Recognition of this pathology is essential because cardiological management is specific and conventional treatments for heart failure can be harmful. Only specific treatments can slow down or stop the infiltration process.

Cardiac amyloidosis diagnostic imaging bone scintigraphy TTR-stabilizing therapy

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.